Down-regulation of BTG1 by miR-454-3p enhances cellular radiosensitivity in renal carcinoma cells

Abstract

BackgroundB cell translocation gene 1 (BTG1) has long been recognized as a tumor suppressor gene. Recent reports demonstrated that BTG1 plays an important role in progression of cell cycle and is involved in cellular response to stressors. However, the microRNAs mediated regulatory mechanism of BTG1 expression has not been reported so far. MicroRNAs can effectively influence tumor radiosensitivity by preventing cell cycle progression, resulting in enhancement of the cytotoxicity of radiotherapy efficacy. This study aimed to demonstrating the effects of microRNAs on the BTG1 expression and cellular radiosensitivity.MethodsThe human renal carcinoma 786-O cells were treated with 5 Gy of X-rays. Expressions of BTG1 gene and miR-454-3p, which was predicted to target BTG1 by software algorithm, were analyzed by quantitative polymerase chain reaction. Protein expressions were assessed by Western blot. Luciferase assays were used to quantify the interaction between BTG1 3′-untranslated region (3′-UTR) and miR-454-3p. The radiosensitivity was quantified by the assay of cell viability, colony formation and caspase-3 activity.ResultsThe expression of the BTG1 gene in 786-O cells was significantly elevated after treatments with X-ray irradiation, DMSO, or serum starvation. The up-regulation of BTG1 after irradiation reduced cellular radiosensitivity as demonstrated by the enhanced cell viability and colony formation, as well as the repressed caspase-3 activity. In comparison, knock down of BTG1 by siRNA led to significantly enhanced cellular radiosensitivity. It was found that miR-454-3p can regulate the expression of BTG1 through a direct interaction with the 3′-UTR of BTG1 mRNA. Decreasing of its expression level correlates well with BTG1 up-regulation during X-ray irradiation. Particularly, we observed that over-expression of miR-454-3p by transfection inhibited the BTG1 expression and enhanced the radiosensitivity. In addition, cell cycle analysis showed that over-expression of miR-454-3p shifted the cell cycle arrest from G2/M phase to S phase.ConclusionsOur results indicate that BTG1 is a direct target of miR-454-3p. Down-regulation of BTG1 by miR-454-3p renders tumor cells sensitive to radiation. These results may shed light on the potential application in tumor radiotherapy.Electronic supplementary materialThe online version of this article (doi:10.1186/1748-717X-9-179) contains supplementary material, which is available to authorized users.

Functions and Mechanisms of Tumor Necrosis Factor-α and Noncoding RNAs in Bone-Invasive Pituitary Adenomas

“…Zhang and colleagues (42) also showed that miR-181c-5p suppresses TLR4 by directly binding to its 3 0 -UTR, thereby inhibited NF-kB activation and the downstream production of proinflammatory mediators, such as TNFa, IL1b, and iNOS. Wu and colleagues (43) reported that miR-454-3p can target BTG1 to render tumor cells sensitive to radiation, and Shao and colleagues reported that plasma miR-454-3p can be a potential prognostic indicator in human glioma (44). lncRNA are involved in diverse biological processes, including the regulation of proliferation, apoptosis, and invasiveness of tumors and reprogramming of induced pluripotent stem cells (45).…”

UBE2D3 gene overexpression increases radiosensitivity of EC109 esophageal cancer cells in vitro and in vivo

“…And cell cycle arrested slightly in G2/M phase allows less time to repair damage thus confer radiation sensitivity [18]. Cellular radiosensitivity can be predicted from the features of the cell cycle redistribution [19]. We placed cells under the linear accelerator with 6 Gy X-ray, which was followed by cell cycle detection.…”

MicroRNA‐19a regulates proliferation and apoptosis of castration‐resistant prostate cancer cells by targeting BTG1

“…BTG1 was recognized as a tumor suppressor gene, and was a important member of the BTG/TOB family of anti‐proliferative genes [23]. Xin reported that over‐expression of BTG1 in human renal carcinoma cells promoted a G1 arrest [24]. Up‐regulation of BTG1 caused higher percentage of the G0/G1 phases and higher cell apoptosis in breast cancer cells by regulating CyclinD1, Bcl‐2, and MMP‐9 protein expression [25].…”